Back to the main directory
Press Release
- Hut 8 Reports Operating and Financial Results for Q3 2023 by GlobeNewsWire
- Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress by GlobeNewsWire
- Schouw & Co. to initiate share buy-back programme of up to DKK 75 million by GlobeNewsWire
- Flagging notification: Shareholding of Aliaxis Holdings SA in Uponor has gone below the threshold of 20 per cent by GlobeNewsWire
- Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged Prostate Compared to Leading Surgical Treatments by GlobeNewsWire
- Castellum, Inc. Announces Third Quarter Financial Results by GlobeNewsWire
- EQS-News: ERFOLGREICHE EINREICHUNG EINES ANTRAGS AUF ZULASSUNG EINES NEUEN PRÜFARZNEIMITTELS (IND) FÜR ACCUTOX® ALS INJZIERBARE BEHANDLUNG GEGEN KREBS BEI SOLIDEN TUMOREN by EQS Group AG
- Asensus Surgical Announces Sale of Senhance Robotic System by GlobeNewsWire
- Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki (AVT04), the First Biosimilar of Stelara® (ustekinumab) by GlobeNewsWire
- Terranet invites to Q3 presentation of Interim Report on November 16, 2023 by GlobeNewsWire
- Terranet bjuder in till presentation av delårsrapport för Q3 den 16 november 2023 by GlobeNewsWire
- Alvotech and JAMP Pharma Announce Receipt of Marketing Authorization for Jamteki™ (AVT04), the First Biosimilar of Stelara® (ustekinumab) by GlobeNewsWire
- K92 Mining Announces Strong 2023 Q3 Financial Results Including Strengthening Financial Position and Process Plant Records by GlobeNewsWire
- Iterum Therapeutics Reports Third Quarter 2023 Financial Results by GlobeNewsWire
- Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update by GlobeNewsWire
- Cellebrite Continues Global Growth with Appointment of First Global Chief Revenue Officer, Marcus Jewell by GlobeNewsWire
- Snail, Inc. to Report Third Quarter 2023 Financial Results by GlobeNewsWire
- Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2023 and Provides Corporate Update by GlobeNewsWire
- Vincerx Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update by GlobeNewsWire
- Gain Therapeutics Announces Third Quarter 2023 Financial Results and Business Update by GlobeNewsWire
- BioXcel Therapeutics Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter 2023 Financial Results by GlobeNewsWire
- Cellebrite Announces Third-Quarter 2023 Results by GlobeNewsWire
- Tingo Group, Inc. Reports Third Quarter 2023 Financial Results by GlobeNewsWire
- atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights by GlobeNewsWire
- EQS-News: CureVac veröffentlicht Finanzergebnisse für das dritte Quartal sowie die ersten neun Monate 2023 und informiert über seine Geschäftsentwicklung by EQS Group AG